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F O R E W O R D
There has been a growing interest in the marine derived bioactivecompounds in the recent years, and the functional foods, enriched
with natural ingredients have been proved to provide beneficial action
for human health. Marine derived bioactive components and the functional food ingredients
demonstrated to possess potential health benefits. High value secondary bioactive
metabolites from the marine organisms are attracting attention because of the growing
demand for new compounds of 'marine natural' origin, having potential applications in
pharmaceutical fields, and concerns about the adverse effects by synthetic drugs and their
derivatives. The pioneering R & D works at ICAR-Central Marine Fisheries Research Institute
on marine bioprospecting envisaged a systematic approach involving chemical profiling of
major species of marine organisms for bioactive pharmacophore leads for activity against
various diseases, and a library of molecules with bioactive potential. The research work in
this institute developed protocols to prepare various pharmaceutical leads, nutraceuticals/
functional food supplements enriched with lead molecules with different properties against
various drug targets for use against various life-threatening diseases.
ICAR-Central Marine Fisheries Research Institute is the pioneering marine research
institute in India to work in the frontier area of bioactive molecule discovery from marine
organisms as promising therapeutic agents against various diseases, aquatic food product
technology, and development of high value products for health management. This prestigious
research institute of Indian Council of Agricultural Research is working in the broad national
interest of producing high value bioactive leads from the marine organisms, which would
provide promising therapeutic agents against various diseases. This institute has developed
and commercialized the nutraceutical products CadalminTM Green Algal extract (CadalminTM
GAe) and Antidiabetic extract (CadalminTM ADe) as green alternatives to synthetic drugs to
combat rheumatic arthritic pains and type-2 diabetes, respectively to a leading
biopharmaceutical company in India. The anti-inflammatory nutraceutical Cadalmin™ Green
Mussel extract (Cadalmin™ GMe) from Asian green mussel Perna viridis has been
commercialized with Amalgam Group of Companies. CadalminTM Antihypercholesterolemic
extract (CadalminTM ACe) has been developed from seaweeds to combat dyslipidemia leading
to obesity, and the product was out-licensed to a leading Indian MNC in wellness and
obesity management. Antimicrobial therapeutic product from marine bacteria as oral
applicant has been developed and the product is in pipeline for commercialization. Seaweed-
derived natural template inspired synthetic derivatives as potential pharmacophores were
designed and developed. Several nutraceutical and cosmeceutical products from marine
organisms are in pipeline, and are being commercialized.
The objective of the National level ICAR Winter School on "Recent advances in bioactive
compounds from marine organisms and development of high-value products for health
management" is to provide up-to-date information and acquaint the participants with the
latest technologies on isolation and characterization of marine natural products of
pharmaceutical importance from marine organisms, general and advanced methods of
isolation procedures by chromatography, classification of organic compounds and their
characterization by advanced spectroscopic experiments. This program further aims to give
exposure to the chemical perspectives of marine organisms, primary and secondary bioactive
metabolites from fish and marine organisms to develop bioactive compounds and high-
value functional food products. Theory and practical classes will be conducted in these
areas to provide the participants a hands-on experience.
This ICAR Winter School is organized with the full funding support from ICAR, New
Delhi, and the twenty-five participants from various parts of India who are attending this
programme were selected after scrutiny of their applications based on their bio-data. They
are serving as academicians, such as Professors/Scientists, and in similar posts. The faculties
include the knowledgeable scientists and professors from various parts of India and abroad.
This training will enable the participants to efficiently carry out their academic programmes,
and to plan research on bioactive molecule discovery in their respective laboratories and
institutes so that they can formulate the strategies for research.
The Winter School on "Recent advances in bioactive compounds from marine organisms
and development of high value products for health management" is very ideal for the
current scenario of increasing lifestyle diseases and human health. Understanding the
importance of natural products in the health care system of India, ICAR-Central Marine
Fisheries Research Institute has reasonably contributed in the various aspects. The Manual
released on this occasion covers all aspects of marine natural products prepared by the
experts in their respective fields. I congratulate the Course Director of this programme, Dr.
Kajal Chakraborty and Head of the Marine Biotechnology Division, Dr. P. Vijayagopal, along
with other staff members of Marine Biotechnology Division and Central Marine Fisheries
Research Institute for their sincere efforts in bringing out the manual in time, and to arrange
the programme in a befitting manner.
A. Gopalakrishnan
Director, ICAR-Central Marine Fisheries Research Institute
Kochi, Kerala
P R E F A C E
Marine-derived bioactive components and the functional food ingredients with potentialhealth benefits are an emerging area of research. The rich diversity of flora and fauna
in the marine and coastal habitats of the Indian subcontinent represent an untapped reservoir
of bioactive compounds with valuable pharmaceutical and biomedical use. Considering the
underutilization of these groups of marine organisms, exploring bioactive compounds and
development of any biologically useful products have benefits as health products.
Comprehensive analyses demonstrated that during the last decade the average proportion
of bioactive compounds among the new compounds is declining, though there are a large
number of marine natural products yet to be explored. This may indicate that the research
level of bioactivity is not keeping up with the discovery of new compounds. Thus, the research
tools and methods for finding bioactivity need to be improved. The first improvement is
about methods of spectral and bioactivity-guided separation and purification of marine-
derived secondary metabolites, which combine the discovery of new compounds. These
improvements in technology are dependent upon the automation in spectroscopy, which
also allows the study of the functions of new compounds extracted from the target marine
organisms. Second, for the discovery of new lead compounds and artificial intelligence for
drug development evolved to a more mechanistic approach that targets specific molecular
lesions. Combined with high-throughput screening through a large number of drug targets,
bioactivity research against various life-threatening diseases will be effective in revealing
the potentially useful biological properties of marine natural products. Furthermore, the
discovery of new bioactive compounds from marine metabolites will form the basis for new
drug leads. Thus, the new compounds will absolutely compose an abundant resource for
future bioactivity research and drug development. Various medicinal and biomedical products
from marine flora and fauna provide a myriad of benefits for human health and multiple
life-threatening diseases, and therefore, are the attractive options for the food and
pharmaceutical industry. The increasing interest in marine-based functional food ingredients
and nutraceutical formulations in the last decade along with increased number of patents
filed/granted have appropriately demonstrated the possibilities of bioactive from marine
organisms to maintain and improve human health and well-being.
The present ICAR Winter School on "Recent advances in bioactive compounds from
marine organisms and development of high-value products for health management" is
designed to acquaint the participants with the advances in marine bioactive compounds
with emphasis on the latest technologies on isolation and characterization of marine natural
products of pharmaceutical importance. The course is planned in such a way that it covers
both theoretical and practical aspect of recent advances in bioactive compounds from marine
organisms. This programme will strengthen the knowledge of participants with regard to
the general and advanced methods of isolation procedures by chromatography, and their
characterization by advanced spectroscopic experiments aspects.
I wish to thank the Education Division of Indian Council of Agricultural Research for
giving us an opportunity to organize this ICAR Winter School. We are grateful to Dr. A.
Gopalakrishnan, Director, ICAR-Central Marine Fisheries Research Institute, for his guidance,
continuous interest in the course and providing all necessary facilities. I am highly obliged
to Dr. P. Vijayagopal, Head, Marine Biotechnology Division for his guidance and support for
the programme. All the scientists of Marine Biotechnology Division, technical staff, supporting
staff and research scholars supported us in organizing the ICAR Winter School. I recall with
gratitude the marvellous effort and help in preparing this manual by Minju Joy, Research
Scholar of Marine Biotechnology Division. I take this opportunity to thank all the faculty
members who have devoted their valuable time and contributed material for the preparation
of the manual. I am confident that the Course Manual would aid the participants to enhance
their knowledge and competence in the area of marine bioactive compounds and their
applications for the development of high-value products for health management.
Kajal Chakraborty
January, 2018 Course Director
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Ocean is a reservoir of millions of flora and fauna; many of which are still unknown to
man. Although exploratory surveys are being carried out by many maritime nations on a
continuous basis to unravel the species diversity and richness of world oceans; our knowledge
of marine biota is very meager. The species unknown to man would be many times more
than the species that are known.  With technological advancements and improved deep-
sea exploratory capabilities, our mission to explore the marine environment has been a
regular process and many species are being discovered and described every day; some of
them even from the abyssal depths.
The marine resources are integral part of human life and man has been dependent on
these resources from time immemorial. The ocean not only provides us protein food, but also
medicines and products which are useful in other industrial applications. The marine natural
products have attracted the attention of biologists and chemists all over the world since the
last five decades and approximately 16,000 marine natural products have been isolated from
marine organisms and reported in approximately 6,800 publications (Dattaet al., 2015). The
marine invertebrates in particular have been attracting the attention of researchers due to the
plethora of bioactive substances hidden in it. Most of the marine invertebrates are known for
their special adaptations to thrive in different environments, to escape from predators, for
prey capture etc. Many of the invertebrates produce bioactive substances ranging from peptides
to alkaloids to trepenoids to steroidsfor defense and preservation of their natural integrity.
Ocean is considered as important source of potential drugs, as some of these bioactive
compounds or secondary metabolites have biomedical potential.
The bioactive substances formed by marine organisms such as protozoans and
invertebrates viz., poriferans, cnidarians, annelids, arthropods, molluscs and echinoderms
have attracted the interest of researchers due to their antiviral, antifungal, antiprotozoal,
antihelminthic and anticancer activities (Zapata and Amemiya, 2000). A vast number of
bioactive compounds are produced by phylogenetically diverse organisms that have different
chemical activity and structure.  Until the end of the first decennium of this century, more
than 15,000 natural compounds that belong to various families of chemicals have been
isolated from marine invertebrates. During the past few years, a large number of novel
compounds have also been reported (Pomponi, 1999;Jimeno, 2002), and some of these
compounds are expected to be used as therapeutics in the near future.
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BIOACTIVE COMPOUNDS FROM CORALS
Cnidarians are well known producers of complex mixtures of proteinaceous toxins used
for defense and for prey capture.In spite of their toxicity, cnidariansare believed to be potential
source of bioactive compounds of pharmaceutical value. The corals, particularly the soft
corals (Alcyonaceans) have been found to possess many secondary metabolites useful in
the pharmaceutical industries. A large number of highly active anti-tumor compounds have
been isolated from many invertebrates including corals. Eleutherobin from Eleutherobia
family of corals, sarcodictyin from Mediterranean Stolonigeran corals are some good
examples. The soft corals have large variety of sesquiterpenoids and Diterpenoids and many
of these compounds were reported as toxic. The soft coral Clavulariaviridiswhich belongs
to the family Clavulariidae is reported to yield cytotoxic steroids, stoloniferones a-d (Kobayashi
et al., 1984). Plexaurahomomallawhich belongs to the family Plexauridae and found in the
Caribbean Sea is one of the richest natural source of prostaglandins, so far discovered in
soft corals. The glycosides, cervicosides and prostanoidsclaviridenones, from the soft corals
Sinulariacervicornisand Clavulariaviridiswere shown to have antitumor activity against human
cancer cell lines (Zhang et al., 2006). A number of diterpenoids of the xenicane groups from
the soft coral, Xenia sp. exhibited mild to-potent cytotoxic activities against human lung
carcinoma (H460) and liver carcinoma (HepG2) cell lines (Su and Wen, 2011).
Secondary bioactive metabolites were also discovered in gorgonians. They are mainly
steroids and terpenoids and several lipid compounds. Pseudopterolide, a diterpene which
exhibited unusual cytotoxic properties was extracted from the gorgonian
Pseudopterogorgiaacerosa(Banduragaet al., 1982). Guaiazulene from thegorgonian
Euplexauraerectaexhibited mild activity against Pseudomonas aeruginosa (Fusetaniet al.,
1981). Subergorgic acid, a cardiotoxinwas obtained from the gorgonidSubergorgiasuberosa
(Groweiss et al., 1985).
BIOACTIVE COMPOUNDS FROM MARINE SPONGES
Sponges occur in marine as well as in freshwater ecosystems; however, a majority of
them are marine. The marine forms are found in inshore as well as in deeper waters. The
‘World Porifera Database’ enlists 8877 valid species of sponges (Van Soestet al., 2018).Sponges
have proved to be the best source among marine organisms of biologically active metabolites
for use as drug leads or biomedical tools (Ireland et al., 1993). Sponges are known for their
capacity to produce bioactive secondary metabolites (Koopmans et al., 2011). More than
5300 different products are recorded from sponges and their associated microorganisms
and every year around 200 new metabolites are reported (Lipton and Shine, 2009).Although
concerted efforts resulted in the development of many new bioactive compounds from
marine sponges, only very few compounds have reached the clinical trial stage. One of the
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reasons for this, as cited by many workers is that many of the sponge bioactive metabolites
are very toxic, thus leading to a low therapeutic index.
In India, at total of 486 species of sponges were reported (Thomas, 1998), the Gulf of
Mannar and Palk Bay has the highest (319 species), followed by Andaman and Nicobar
Islands (95 species), Lakshadweep (82 species) and Gulf of Kachchh (25 species)
(Venkataraman, 2005). According to (Sivaleela 2014), the Gulf of Mannar and Palk Bay
accounts for over 67% of sponge diversity of India. The sponge fauna of India is dominated
by species of Demospongia followed by Hyalospongiae and Calciospongiae (Venkataraman,
2005). A recent report on the sponge diversity in India by Chandra et al. (2016) listed 476
species; the Palk Bay and the Gulf of Mannar having the highest species diversity (329
species), followed by Andaman and Nicobar Islands (126 species).
The pioneering discovery of bioactive compounds from marine sources was the
serendipitous isolation of C-Nucleosides, spongouridine and spongothymidine from the
Caribbean sponge Cryptotheca crypt in early1950s (Bergmann and Feeney, 1950). These
compounds have potential antiviral activity and their synthetic analog was an anticancer
drug (McConnell etal., 1994). The compound Manzamine A has potent antimalarial activity
against rodent malarialparasite Plasmodium bergheiin vivo (Anget al., 2000). There are
severalbioactive compounds viz. sterols, terpenoids, phenolic or quinoid, carotenoids etc.
frommarine sponges reported for medicinal values.
Marine sponges are a good source of unusualsterols and the sulphated andalkaloid
sterols have exhibited antimicrobial activity. A bioactive compound, halistanol was reported
from the sponge Halichondriamooriei (Fusetaniet al.,1981). Halistanoltrisulfate, a sulfated
steroidderivative was isolated from the extracts of Topsentia spp.(Slate et al., 1995). Townsend
et al. (1992) reported that the pigmentedhuman melanoma cell line, MM418, became
demelanizedwhen treated continuously with halistanoltrisulphate (HTS), a C29 steroidal
detergent isolated from a marine sponge. The steroidal alkaloids plakinamine A and
plakinamine B which are antimicrobial metabolites were obtained from Plakinasp. and the
compound was found to inhibit the growth of Staphylococcus aureusand Candida
albicans(Rosser and Faulkner, 1984). The sterols from the sponge Toxadociazumiinhibited
the growth of two species of bacteria namely Staphylococcus aureusand Bacillus subtitis
(Nakasuet al., 1983).
The extracts of Zygomycalesp. showed potent antibacterial activity against bacteria
such as Bacillus megaterium, Klebsiellapneumoniaeand Sterptococcuspyogenesand exhibited
antifungal activity against all pathogenic test strains (Johnson et al., 2012). Spongiaofficinalis,
the common bath sponge is a rich source of terpenoids. The compounds sesquiterpenoid
and avarol, which exhibited antimicrobialactivity and also found active against “AIDS” virus
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was first isolated from a Mediterraneansponge Disideaavara(Minaleet al., 1974). The
compound triprenylphenols have been isolated from the red sponge Halichondria panacea
(Ciminoet al., 1973;Casapulloet al., 1993;Jasparset al., 1995). Phyllofenone A and 20, 24-
diethyl-25-norscalorane sesterterpene with antifungal activity from sponge
Phyllospongiafoliascenshave been isolated by Kimuchiet al., (1981; 1983).
CONCLUSION
Sponges are often known to produce metabolites which are beneficial to mankind,
however the main issue is the production of requisite biomass as sponges produce
metabolites in trace quantities (Osingaet al., 1999). Hence, in order to having potential
applications in various fields, and production of metabolites in trace quantities creates an
issue with respect to mass production. Large quantities of sponges are to be exploited in
order to produce considerable quantity of required metabolites. The available natural
population of sponges will not be sufficient enough for utilization as it could threaten the
existing natural stock. Culturing sponges is a way to address supply problem (Laportet al.,
2009), as aquaculture is one of the best possible methods to produce large quantity of
requisite sponge biomass. With the advancement of aquaculture technologies in recent
days, it is easy to produce large biomass of sponges without harnessing its natural
populations. Sponges have been experimentally farmed for over 100 years with early attempts
done in the sea to supply bath sponges (Duckworth, 2009). For commercial sponge
aquaculture, increased productions of sponge biomass coupled with retaining high
biosynthesis of target bioactive metabolites are the major pre-requisites (Duckworth and
Battershill, 2003). The similar is the case with soft corals too. There is a need to develop
suitable culture techniques for some of the potential soft coral species for mass production
which can be utilized for extraction of compounds.
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